Vaxcyte, Inc(NASDAQ:PCVX) 
Vaxcyte, Inc., a preclinical-stage biotechnology vaccine company, develops novel vaccines to prevent or treat infectious diseases worldwide. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine. The company also develops VAX-XP to protect against emerging ...
Website: http://www.vaxcyte.com
Founded: 2013
CEO: Grant E. Pickering
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 30.17
H 33.25
L 29.57
C 31.60
V 5,690,353
10EMA 31.60
20EMA 31.60
60EMA 31.60
120EMA 31.60
250EMA 31.60